Innovation Support Unit (UAI)
Spin-offs established at the IiSGM
At the Gregorio Marañón Health Research Institute, our spin-offs are the tangible expression of how we turn research into solutions for healthcare needs.
These start-ups, born from research and knowledge, are the bridge that carries innovation from the laboratory to society.
Discover how we are transforming knowledge into impact, creating value and improving people's lives through our entrepreneurial initiatives
Corify care
Corify Care was founded on the idea that it is possible to improve the diagnosis and treatment of cardiac arrhythmias.
The spin-off will bring to market the ACORYS medical device, which maps cardiac arrhythmias non-invasively and in real time. This novel technology will improve the treatment of more than 10 million patients with atrial fibrillation in Europe alone.
Telara Pharma
This spin-off was born from the research carried out by Dr Alberto Tejedor and aims to commercialise the compound cilastatin to prevent and treat acute kidney injury. It has recently completed an investment round and signed an exclusive worldwide licence agreement with the Canadian company Arch Biopartners.
THYTECH
This company arises from the work carried out by the researchers of the immunoregulation laboratory. It consists of the administration of thyTreg cells derived from the thymus which, thanks to their suppressive and regulatory effect, are able to control inappropriate immune responses. This therapy, already approved by the Spanish Agency of Medicines and Medical Devices (AEMPS), is currently being administered to children who have received a heart transplant to prevent organ rejection, and could be effective in the treatment of multiple diseases.
OWNMED INNOVATION
Ownmed's core technology, Ostofix®, is a revolutionary ostomy device designed for ostomy patients. With its unique ability to manage waste material, Ostofix® sets a new benchmark in ostomy care, ensuring optimal comfort and functionality for patients. It is currently under development.